- Home
- KIM vs CRL Comparison
KIM vs CRL Comparison
Compare KIM & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIM | CRL |
|---|---|---|
| Founded | 1958 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 13.1B |
| IPO Year | 1994 | 1999 |
Fundamental Metrics
Financial Performance| Metric | KIM | CRL |
|---|---|---|
| Price | $23.75 | $354.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 17 |
| Target Price | $25.82 | ★ $314.20 |
| AVG Volume (30 Days) | ★ 4.1M | 1.0M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 4.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $2,140,116,000.00 | $1,857,601,000.00 |
| Revenue This Year | $2.63 | N/A |
| Revenue Next Year | $3.16 | $2.53 |
| P/E Ratio | $52.53 | ★ N/A |
| Revenue Growth | 5.06 | ★ 10.48 |
| 52 Week Low | $19.76 | $146.20 |
| 52 Week High | $26.65 | $351.21 |
Technical Indicators
Market Signals| Indicator | KIM | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 65.96 | 75.40 |
| Support Level | $23.36 | $147.39 |
| Resistance Level | $24.16 | N/A |
| Average True Range (ATR) | 0.37 | 12.93 |
| MACD | 0.21 | 4.86 |
| Stochastic Oscillator | 95.52 | 95.09 |
Price Performance
Historical ComparisonAbout KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 565 shopping centers throughout major markets in the US, representing roughly 100 million square feet.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.